308 related articles for article (PubMed ID: 32373131)
21. Effect of Combination Antiretroviral Therapy on HIV-1-specific Antibody-Dependent Cellular Cytotoxicity Responses in Subtype B- and Subtype C-Infected Cohorts.
Madhavi V; Kulkarni A; Shete A; Lee WS; Mclean MR; Kristensen AB; Ghate M; Wines BD; Hogarth PM; Parsons MS; Kelleher A; Cooper DA; Amin J; Emery S; Thakar M; Kent SJ;
J Acquir Immune Defic Syndr; 2017 Jul; 75(3):345-353. PubMed ID: 28346319
[TBL] [Abstract][Full Text] [Related]
22. Follicular CD8 T cells accumulate in HIV infection and can kill infected cells in vitro via bispecific antibodies.
Petrovas C; Ferrando-Martinez S; Gerner MY; Casazza JP; Pegu A; Deleage C; Cooper A; Hataye J; Andrews S; Ambrozak D; Del Río Estrada PM; Boritz E; Paris R; Moysi E; Boswell KL; Ruiz-Mateos E; Vagios I; Leal M; Ablanedo-Terrazas Y; Rivero A; Gonzalez-Hernandez LA; McDermott AB; Moir S; Reyes-Terán G; Docobo F; Pantaleo G; Douek DC; Betts MR; Estes JD; Germain RN; Mascola JR; Koup RA
Sci Transl Med; 2017 Jan; 9(373):. PubMed ID: 28100833
[TBL] [Abstract][Full Text] [Related]
23. A Novel Toll-Like Receptor 9 Agonist, MGN1703, Enhances HIV-1 Transcription and NK Cell-Mediated Inhibition of HIV-1-Infected Autologous CD4+ T Cells.
Offersen R; Nissen SK; Rasmussen TA; Østergaard L; Denton PW; Søgaard OS; Tolstrup M
J Virol; 2016 May; 90(9):4441-4453. PubMed ID: 26889036
[TBL] [Abstract][Full Text] [Related]
24. Lysis of endogenously infected CD4+ T cell blasts by rIL-2 activated autologous natural killer cells from HIV-infected viremic individuals.
Fogli M; Mavilio D; Brunetta E; Varchetta S; Ata K; Roby G; Kovacs C; Follmann D; Pende D; Ward J; Barker E; Marcenaro E; Moretta A; Fauci AS
PLoS Pathog; 2008 Jul; 4(7):e1000101. PubMed ID: 18617991
[TBL] [Abstract][Full Text] [Related]
25. Therapeutic Targeting of HIV Reservoirs: How to Give T Cells a New Direction.
Yang H; Wallace Z; Dorrell L
Front Immunol; 2018; 9():2861. PubMed ID: 30564246
[TBL] [Abstract][Full Text] [Related]
26. Elimination of Latently HIV-infected Cells from Antiretroviral Therapy-suppressed Subjects by Engineered Immune-mobilizing T-cell Receptors.
Yang H; Buisson S; Bossi G; Wallace Z; Hancock G; So C; Ashfield R; Vuidepot A; Mahon T; Molloy P; Oates J; Paston SJ; Aleksic M; Hassan NJ; Jakobsen BK; Dorrell L
Mol Ther; 2016 Nov; 24(11):1913-1925. PubMed ID: 27401039
[TBL] [Abstract][Full Text] [Related]
27. Generation propagation, and targeting of human CD4+ helper/killer T cells induced by anti-CD3 monoclonal antibody plus recombinant IL-2. An efficient strategy for adoptive tumor immunotherapy.
Nishimura T; Nakamura Y; Takeuchi Y; Tokuda Y; Iwasawa M; Kawasaki A; Okumura K; Habu S
J Immunol; 1992 Jan; 148(1):285-91. PubMed ID: 1345787
[TBL] [Abstract][Full Text] [Related]
28. HLA-C and HLA-E reduce antibody-dependent natural killer cell-mediated cytotoxicity of HIV-infected primary T cell blasts.
Ward JP; Bonaparte MI; Barker E
AIDS; 2004 Sep; 18(13):1769-79. PubMed ID: 15316337
[TBL] [Abstract][Full Text] [Related]
29. Antibody from patients with acute human immunodeficiency virus (HIV) infection inhibits primary strains of HIV type 1 in the presence of natural-killer effector cells.
Forthal DN; Landucci G; Daar ES
J Virol; 2001 Aug; 75(15):6953-61. PubMed ID: 11435575
[TBL] [Abstract][Full Text] [Related]
30. T cell interleukin-15 surface expression in chimpanzees infected with human immunodeficiency virus.
Rodriguez AR; Hodara V; Murthy K; Morrow L; Sanchez M; Bienvenu AE; Murthy KK
Cell Immunol; 2014; 288(1-2):24-30. PubMed ID: 24565973
[TBL] [Abstract][Full Text] [Related]
31. Innate Immune Activity Correlates with CD4 T Cell-Associated HIV-1 DNA Decline during Latency-Reversing Treatment with Panobinostat.
Olesen R; Vigano S; Rasmussen TA; Søgaard OS; Ouyang Z; Buzon M; Bashirova A; Carrington M; Palmer S; Brinkmann CR; Yu XG; Østergaard L; Tolstrup M; Lichterfeld M
J Virol; 2015 Oct; 89(20):10176-89. PubMed ID: 26223643
[TBL] [Abstract][Full Text] [Related]
32. The HIV Latency Reversal Agent HODHBt Enhances NK Cell Effector and Memory-Like Functions by Increasing Interleukin-15-Mediated STAT Activation.
Macedo AB; Levinger C; Nguyen BN; Richard J; Gupta M; Cruz CRY; Finzi A; Chiappinelli KB; Crandall KA; Bosque A
J Virol; 2022 Aug; 96(15):e0037222. PubMed ID: 35867565
[TBL] [Abstract][Full Text] [Related]
33. Improved killing of HIV-infected cells using three neutralizing and non-neutralizing antibodies.
Tuyishime M; Garrido C; Jha S; Moeser M; Mielke D; LaBranche C; Montefiori D; Haynes BF; Joseph S; Margolis DM; Ferrari G
J Clin Invest; 2020 Oct; 130(10):5157-5170. PubMed ID: 32584790
[TBL] [Abstract][Full Text] [Related]
34. Flow cytometric characterization of human umbilical cord blood lymphocytes: immunophenotypic features.
D'Arena G; Musto P; Cascavilla N; Di Giorgio G; Fusilli S; Zendoli F; Carotenuto M
Haematologica; 1998 Mar; 83(3):197-203. PubMed ID: 9573672
[TBL] [Abstract][Full Text] [Related]
35. Gene therapy approaches to HIV-infection: immunological strategies: use of T bodies and universal receptors to redirect cytolytic T-cells.
Bitton N; Gorochov G; Debre P; Eshhar Z
Front Biosci; 1999 Apr; 4():D386-93. PubMed ID: 10099136
[TBL] [Abstract][Full Text] [Related]
36. Natural killer cytotoxicity and antibody-dependent cellular cytotoxicity of human immunodeficiency virus-infected cells by leukocytes from human neonates and adults.
Jenkins M; Mills J; Kohl S
Pediatr Res; 1993 May; 33(5):469-74. PubMed ID: 8511019
[TBL] [Abstract][Full Text] [Related]
37. Cooperativity of HIV-Specific Cytolytic CD4 T Cells and CD8 T Cells in Control of HIV Viremia.
Johnson S; Eller M; Teigler JE; Maloveste SM; Schultz BT; Soghoian DZ; Lu R; Oster AF; Chenine AL; Alter G; Dittmer U; Marovich M; Robb ML; Michael NL; Bolton D; Streeck H
J Virol; 2015 Aug; 89(15):7494-505. PubMed ID: 25972560
[TBL] [Abstract][Full Text] [Related]
38. IFN-α augments natural killer-mediated antibody-dependent cellular cytotoxicity of HIV-1-infected autologous CD4+ T cells regardless of major histocompatibility complex class 1 downregulation.
Tomescu C; Tebas P; Montaner LJ
AIDS; 2017 Mar; 31(5):613-622. PubMed ID: 28225449
[TBL] [Abstract][Full Text] [Related]
39. HIV-infected macrophages resist efficient NK cell-mediated killing while preserving inflammatory cytokine responses.
Clayton KL; Mylvaganam G; Villasmil-Ocando A; Stuart H; Maus MV; Rashidian M; Ploegh HL; Walker BD
Cell Host Microbe; 2021 Mar; 29(3):435-447.e9. PubMed ID: 33571449
[TBL] [Abstract][Full Text] [Related]
40. Natural killer cells from human immunodeficiency virus (HIV)-infected individuals are an important source of CC-chemokines and suppress HIV-1 entry and replication in vitro.
Oliva A; Kinter AL; Vaccarezza M; Rubbert A; Catanzaro A; Moir S; Monaco J; Ehler L; Mizell S; Jackson R; Li Y; Romano JW; Fauci AS
J Clin Invest; 1998 Jul; 102(1):223-31. PubMed ID: 9649576
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
